Your browser doesn't support javascript.
loading
Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
Aoki, Shiro; Hosomi, Naohisa; Sueda, Yoshimasa; Kono, Tomoyuki; Takamatsu, Kazuhiro; Ohyama, Hideo; Torii, Tsuyoshi; Kitamura, Takeshi; Nomura, Eiichi; Noda, Koichi; Ohtsuki, Toshiho; Matsumoto, Masayasu.
Afiliação
  • Aoki S; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Hosomi N; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan. Electronic address: nhosomi@hiroshima-u.ac.jp.
  • Sueda Y; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan; Department of Neurology, National Hospital Organization Kure Medical Center, Kure, Japan.
  • Kono T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Takamatsu K; Department of Neurology, Brain Attack Center Ota Memorial Hospital, Fukuyama, Japan.
  • Ohyama H; Department of Cardiology, Osaka Neurosurgical Hospital, Kagawa, Japan.
  • Torii T; Department of Neurology, National Hospital Organization Kure Medical Center, Kure, Japan.
  • Kitamura T; Department of Neurology, Chugoku Rosai Hospital, Kure, Japan.
  • Nomura E; Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan.
  • Noda K; Department of Neurology, National Hospital Organization Higashihiroshima Medical Center, Higashihiroshima, Japan.
  • Ohtsuki T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Matsumoto M; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
J Stroke Cerebrovasc Dis ; 24(12): 2747-53, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26360972
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Trombolítica / Isquemia Encefálica / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Fibrinolíticos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Trombolítica / Isquemia Encefálica / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Fibrinolíticos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2015 Tipo de documento: Article